AU Patent

AU2008279379B2 — Natriuretic polypeptides

Assigned to Mayo Clinic in Florida · Expires 2016-03-24 · 10y expired

What this patent protects

This document provides natriuretic polypeptides. For example, this document provides polypeptides having a natriuretic activity. In some cases, a polypeptide provided herein can have natriuretic activities, while lacking the ability to lower blood pressure. This document also pro…

USPTO Abstract

This document provides natriuretic polypeptides. For example, this document provides polypeptides having a natriuretic activity. In some cases, a polypeptide provided herein can have natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing natriuretic activities within a mammal.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008279379B2
Jurisdiction
AU
Classification
—
Expires
2016-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Mayo Clinic in Florida
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.